methotrexate 1 GM per 40 ML Injection
- RxCUI
- 1655956
- RxNorm name
- methotrexate 1 GM per 40 ML Injection
- Display name
- methotrexate 1 GM per 40 ML Injection
- Full name
- methotrexate 1 GM per 40 ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:47
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| METHOTREXATE | METHOTREXATE | Alembic Pharmaceuticals Inc. | a63364d5-4dfa-49d7-8a5e-c8959ae1d37a | 2026-04-16 | Boxed warning, Warnings, Adverse reactions | 1655956 |
| METHOTREXATE | METHOTREXATE | Alembic Pharmaceuticals Limited | e98b2abd-8068-482e-9ce3-1ab262f0838e | 2026-04-16 | Boxed warning, Warnings, Adverse reactions | 1655956 |
| Methotrexate | METHOTREXATE | Hospira, Inc. | 0e30eaef-5a09-4104-8a11-c32933eadeab | 2025-08-22 | Boxed warning, Warnings, Adverse reactions | 1655956 |
| Methotrexate | METHOTREXATE | Teva Parenteral Medicines, Inc. | 346ec9ce-dc98-4a55-b55e-d3af11f2d703 | 2025-07-15 | Boxed warning, Warnings, Adverse reactions | 1655956 |
| Methotrexate | METHOTREXATE | Hospira, Inc. | bd287e89-32f9-4396-95fa-4b562869f476 | 2025-06-30 | Boxed warning, Warnings, Adverse reactions | 1655956 |
| Methotrexate | METHOTREXATE | Hospira, Inc. | 0d63ba29-b692-41b4-87e8-351265c8273f | 2025-06-10 | Boxed warning, Warnings, Adverse reactions | 1655956 |
| Methotrexate | METHOTREXATE | Accord Healthcare, Inc. | dd035a9f-cd40-4314-b9d8-2294b8a924e2 | 2025-01-14 | Boxed warning, Warnings, Adverse reactions | 1655956 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 0d63ba29-b692-41b4-87e8-351265c8273f | methotrexate 1 GM in 40 ML Injection [PSN] · 40 ML methotrexate 25 MG/ML Injection [SCD] · methotrexate 1 GM per 40 ML Injection [SY] | 3 | 19 | These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953 | 20250610 |
| 0e30eaef-5a09-4104-8a11-c32933eadeab | methotrexate 1 GM in 40 ML Injection [PSN] · 40 ML methotrexate 25 MG/ML Injection [SCD] · methotrexate 1 GM per 40 ML Injection [SY] | 3 | 17 | These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953 | 20250822 |
| 346ec9ce-dc98-4a55-b55e-d3af11f2d703 | methotrexate 1 GM in 40 ML Injection [PSN] · 40 ML methotrexate 25 MG/ML Injection [SCD] · methotrexate 1 GM per 40 ML Injection [SY] | 3 | 11 | These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953 | 20250715 |
| bd287e89-32f9-4396-95fa-4b562869f476 | methotrexate 1 GM in 40 ML Injection [PSN] · 40 ML methotrexate 25 MG/ML Injection [SCD] · methotrexate 1 GM per 40 ML Injection [SY] | 3 | 6 | These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953 | 20250630 |
| dd035a9f-cd40-4314-b9d8-2294b8a924e2 | methotrexate 1 GM in 40 ML Injection [PSN] · 40 ML methotrexate 25 MG/ML Injection [SCD] · methotrexate 1 GM per 40 ML Injection [SY] | 3 | 6 | These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953 | 20250114 |
| a63364d5-4dfa-49d7-8a5e-c8959ae1d37a | methotrexate 1 GM in 40 ML Injection [PSN] · 40 ML methotrexate 25 MG/ML Injection [SCD] · methotrexate 1 GM per 40 ML Injection [SY] | 3 | 4 | These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953 | 20260416 |
| e98b2abd-8068-482e-9ce3-1ab262f0838e | methotrexate 1 GM in 40 ML Injection [PSN] · 40 ML methotrexate 25 MG/ML Injection [SCD] · methotrexate 1 GM per 40 ML Injection [SY] | 3 | 1 | These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 1953 | 20260416 |